Clinical Trials Directory

Trials / Completed

CompletedNCT00901017

Comparison of Synthetic Bone Substitute and a Bovine-derived Xenograft in Horizontal Bone Augmentation

A Randomised Controlled Spilt-mouth Clinical Study Comparing a Synthetic Bone Substitute and a Bovine-derived Xenograft in Primarily Horizontal Bone Augmentation Procedure During Placement of Straumann Oral Implants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Institut Straumann AG · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The objective of the study is to test the efficacy on bone formation of Straumann Bone Ceramic as a grafting material applied in buccal bone dehiscences on simultaneously placed oral implants.

Detailed description

This is a randomized, controlled, split mouth, prospective, single centre study. The total study duration for each patient should be 76 weeks +/-18 months. In total 8 visits per patient are scheduled in this study. The study devices Straumann Bone Ceramic and Bio-Oss are CE-marked, and approved by the FDA. The products are used within the indication. One center in Beligum will participate.

Conditions

Interventions

TypeNameDescription
DEVICEStraumann BoneCeramicBone augmentation procedure performed with Bone Ceramic
DEVICEBio-OssBone Augmentation procedure performed with Bio Oss

Timeline

Start date
2006-03-01
Primary completion
2008-02-01
Completion
2008-08-01
First posted
2009-05-13
Last updated
2016-03-30
Results posted
2012-11-05

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT00901017. Inclusion in this directory is not an endorsement.